About this document
Articulo Salud by Nicolas Mateo Gonzalez Lopez is a document available to read on EtoBox.
Li et al. demonstrate that anti-CD19 CAR T cell therapy is a safe and effective treatment for refractory systemic lupus erythematosus with immune thrombocytopenia (SLE-ITP), with all six patients achieving clinical responses. While three patients attained complete remission, partial responses were linked to ongoing bone marrow B cell activation and impaired platelet production. The study highlights the need for larger trials to confirm these findings and explore the underlying mechanisms affecting treatment
- Author
- Nicolas Mateo Gonzalez Lopez
- Language
- EN